Characterization of novel human UDP glycosyltransferases [ 2004 - 2006 ]

Research Grant

Researchers: E/Pr Peter Mackenzie (Principal investigator) ,  Prof John Miners

Brief description Our defense against the toxic effects of small organic molecules is mediated by families of enzymes found in the internal membranes of cells, predominantly in the liver and gastrointestinal tract. Many small organic molecules, such as environmental pollutants, carcinogens and therapeutic drugs, are fat-soluble and will accumulate in the body to toxic levels unless they are modified by the addition of water-soluble groups. The modified chemical, in the majority of cases, is less toxic and readily removed from the body. One aim of this project is to identify and characterize newly discovered enzymes in the family that uses sugar residues to modify and eliminate fat-soluble chemicals. Their involvement in the detoxification process and how they are controlled in the cell will be determined. These are the final enzymes in this family remaining to be characterized in humans. In addition to foreign chemicals and toxins, this enzyme family also regulates the intracellular concentrations of signalling molecules such as steroid hormones and chemicals that bind to gene regulatory proteins. Defects and-or variations in these enzymes may alter the levels of these signalling molecules and lead to uncontrolled cell growth (cancer) or cell death. A second aim of this project is to determine whether these novel enzymes are involved in controlling signal concentrations and to determine whether inherited variations in these enzymes will alter the signalling process.

Funding Amount $AUD 417,750.00

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant